[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 1983

Aqueous Penetration of Oral and Topical Indomethacin in Humans

Author Affiliations

From the Departments of Ophthalmology (Drs Sanders, Goldstick, Kraff, and Hutchins) and Pharmacology (Drs Sanders and Evans and Mr Bernstein), Abraham Lincoln School of Medicine, University of Illinois at the Medical Center, Chicago.

Arch Ophthalmol. 1983;101(10):1614-1616. doi:10.1001/archopht.1983.01040020616024

• Aqueous humor and serum indomethacin levels were determined following administration of the drug orally, as a topical 1% aqueous suspension and as a topical 1% oil suspension. Patients receiving indomethacin orally had a mean aqueous humor level below the lower limit of sensitivity of the assay, which is also below the level known to inhibit prostaglandin synthesis in vitro and a mean serum level of 642 ng/mL. Patients receiving the topical 1% aqueous suspension had a mean aqueous level of 198 ng/mL and no detectable serum level. Patients receiving the topical 1% oil suspension had a mean aqueous level of 429 ng/mL, which was significantly higher than that of the aqueous suspension. Both topical suspensions yield levels that are able to inhibit prostaglandin synthesis. Higher aqueous levels with no detectable blood levels (and thus negligible potential for systemic toxic effects) make the topical route of administration preferable to the oral route.